13 February 2019 in IEEE Journal of Biomedical and Health Informatics
The diagnosis of type 2 diabetes (T2D) at an early stage has a key role for an adequate T2D integrated management system and patient's follow-up. Recent years have witnessed an increasing amount of available electronic health record (EHR) data and machine learning (ML) techniques have been considerably evolving. However, managing and modeling this amount of information may lead to several challenges, such as overfitting, model interpretability, and computational cost. Starting from these motivations, we introduced an ML method called sparse balanced support vector machine (SB-SVM) for discovering T2D in a novel collected EHR dataset (named Federazione Italiana Medici di Medicina Generale dataset). In particular, among all the EHR features related to exemptions, examination, and drug prescriptions, we have selected only those collected before T2D diagnosis from an uniform age group of subjects. We demonstrated the reliability of the introduced approach with respect to other ML and deep learning approaches widely employed in the state-of-the-art for solving this task. Results evidence that the SB-SVM overcomes the other state-of-the-art competitors providing the best compromise between predictive performance and computation time. Additionally, the induced sparsity allows to increase the model interpretability, while implicitly managing high-dimensional data and the usual unbalanced class distribution.
22 June 2023 in Computers in Biology and Medicine
The missing data mechanism is a relevant problem in Machine Learning (ML) and biomedical informatics communities. Real-world Electronic Health Record (EHR) datasets comprise several missing values, thus revealing a high level of spatiotemporal sparsity in the predictors' matrix. Several approaches in the state-of-the-art tried to deal with this problem by proposing different data imputation strategies that (i) are often unrelated to the ML model, (ii) are not conceived for EHR data where laboratory exams are not prescribed uniformly over time and percentage of missing values is high (iii) exploit only univariate and linear information on the observed features. Our paper proposes a data imputation strategy based on a clinical conditional Generative Adversarial Network (ccGAN) capable of imputing missing values by exploiting non-linear and multivariate information across patients. Unlike other GAN data imputation-based approaches, our method deals explicitly with the high level of missingness of routine EHR data by conditioning the imputing strategy to the observable values and those fully-annotated. We demonstrated the statistical significance of the ccGAN to other state-of-the-art approaches in terms of imputation (around 19.79% of gain to the best competitor) and predictive performance (up to 1.60% of gain to the best competitor) on a real multi-diabetic centers dataset. We also demonstrated its robustness across different missingness rates (up to 1.61% of gain to the best competitor in the highest missingness rates condition) on an additional benchmark EHR dataset.
1 May 2020 in Artificial Intelligence in Medicine
20 April 2021 in IEEE Journal of Biomedical and Health Informatics
Kidney Disease (KD) may hide complex causes and is associated with a tremendous socio-economic impact. A timely identification and management from the first level of medical care represent the most effective strategy to address the growing global burden sustainably. Clinical practice guidelines suggest utilizing estimated Glomerular Filtration Rate (eGFR) for routine evaluation within a screening purpose. Accordingly, the analysis of Electronic Health Records (EHRs) using Machine Learning techniques offers great opportunities to monitor and predict the eGFR trend over time. This paper aims to propose a novel Semi-Supervised Multi-Task Learning (SS-MTL) approach for predicting short-term KD evolution on multiple General Practitioners EHR data. We demonstrated that the SS-MTL approach is able to (i) capture the eGFR temporal evolution by imposing a temporal relatedness between consecutive time-windows and (ii) exploit useful information from unlabeled patients when labeled patients are less numerous with a gain of up to 4.1 % in terms of Recall. This situation reflects the real-case scenario, where available labeled samples are limited, but those unlabeled much more abundant. The SS-MTL approach, also given the high level of interpretability, might be the ideal candidate in general practice to get integrated within a decision support system for KD screening purposes.
1 January 2020 in IEEE Journal of Translational Engineering in Health and Medicine
Objective Decision support systems (DSS) have been developed and promoted for their potential to improve quality of health care. However, there is a lack of common clinical strategy and a poor management of clinical resources and erroneous implementation of preventive medicine. Methods To overcome this problem, this work proposed an integrated system that relies on the creation and sharing of a database extracted from GPs' Electronic Health Records (EHRs) within the Netmedica Italian (NMI) cloud infrastructure. Although the proposed system is a pilot application specically tailored for improving the chronic Type 2 Diabetes (T2D) care it could be easily targeted to effectively manage different chronicdiseases. The proposed DSS is based on EHR structure used by GPs in their daily activities following the most updated guidelines in data protection and sharing. The DSS is equipped with a Machine Learning (ML) method for analyzing the shared EHRs and thus tackling the high variability of EHRs. A novel set of T2D care-quality indicators are used specically to determine the economic incentives and the T2D features are presented as predictors of the proposed ML approach. Results The EHRs from 41237 T2D patients were analyzed. No additional data collection, with respect to the standard clinical practice, was required. The DSS exhibited competitive performance (up to an overall accuracy of 98% +/- 2% and macro-recall of 96%+/- 1%) for classifying chronic care quality across the different follow-up phases. The chronic care quality model brought to a signicant increase (up to 12%) of the T2D patients without complications. For GPs who agreed to use the proposed system, there was an economic incentive. A further bonus was assigned when performance targets are achieved. Conclusions The quality care evaluation in a clinical use-case scenario demonstrated how the empowerment of the GPs through the use of the platform (integrating the proposed DSS), along with the economic incentives, may speed up the improvement of care.